Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.71 $1.96 Friday, 10th May 2024 SYBX stock ended at $1.79. This is 2.19% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 2.23% from a day low at $1.79 to a day high of $1.83.
90 days $1.55 $2.16
52 weeks $0.234 $5.71

Historical Synlogic Inc prices

Date Open High Low Close Volume
Aug 30, 2023 $0.500 $0.505 $0.480 $0.486 38 685
Aug 29, 2023 $0.484 $0.508 $0.470 $0.502 55 851
Aug 28, 2023 $0.525 $0.525 $0.472 $0.489 24 648
Aug 25, 2023 $0.485 $0.505 $0.460 $0.495 82 836
Aug 24, 2023 $0.500 $0.504 $0.475 $0.484 162 973
Aug 23, 2023 $0.521 $0.548 $0.490 $0.511 116 870
Aug 22, 2023 $0.560 $0.567 $0.500 $0.521 163 043
Aug 21, 2023 $0.540 $0.590 $0.530 $0.540 238 826
Aug 18, 2023 $0.490 $0.540 $0.490 $0.525 54 446
Aug 17, 2023 $0.545 $0.545 $0.490 $0.504 147 882
Aug 16, 2023 $0.545 $0.545 $0.510 $0.526 71 259
Aug 15, 2023 $0.534 $0.549 $0.503 $0.531 88 991
Aug 14, 2023 $0.520 $0.530 $0.510 $0.511 65 304
Aug 11, 2023 $0.498 $0.540 $0.494 $0.510 141 253
Aug 10, 2023 $0.493 $0.500 $0.480 $0.498 37 283
Aug 09, 2023 $0.490 $0.500 $0.490 $0.490 35 638
Aug 08, 2023 $0.540 $0.540 $0.485 $0.485 41 859
Aug 07, 2023 $0.553 $0.553 $0.490 $0.497 150 933
Aug 04, 2023 $0.509 $0.511 $0.480 $0.500 68 843
Aug 03, 2023 $0.510 $0.530 $0.509 $0.510 71 567
Aug 02, 2023 $0.519 $0.528 $0.500 $0.517 60 686
Aug 01, 2023 $0.490 $0.520 $0.475 $0.520 100 758
Jul 31, 2023 $0.500 $0.508 $0.487 $0.490 131 664
Jul 28, 2023 $0.489 $0.490 $0.451 $0.489 172 069
Jul 27, 2023 $0.486 $0.507 $0.440 $0.480 196 675
Click to get the best stock tips daily for free!

About Synlogic Inc

Synlogic Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase II clinical trials to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed... SYBX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT